TMO - Revvity: Enter Now As Reorganization Takes Shape
2024-03-21 11:27:34 ET
Summary
- Revvity, Inc. is a major laboratory instrument and service provider to the healthcare industry.
- The company has historically underperformed compared to its peers in terms of profit generation and growth.
- Revvity has implemented a business restructuring plan and aims to drive differentiation through inorganic investments in high-margin areas.
Introduction
Revvity, Inc ( RVTY ), formerly known as PerkinElmer, is a major laboratory instrument and service provider to the healthcare industry. According to data from instrument platform manufacturers such as Tecan Group ( OTCPK:TCHBF ), Revvity is a provider of niche assay specialties such as DELFIA, Alpha38, and BRET2, along with high end analytical equipment. Also, the company remains the primary choice for prenatal and newborn screening, with the newborn heel prick remaining the industry choice (70% market share and state mandated procedure). Across the entire product portfolio, Revvity has generated enough superiority to earn a “narrow moat” rating from Morningstar....
Revvity: Enter Now As Reorganization Takes Shape